Aimei Health Technology Co., Ltd (NASDAQ:AFJK - Get Free Report) fell 0.5% during trading on Thursday . The company traded as low as $11.00 and last traded at $10.96. 301 shares were traded during trading, a decline of 99% from the average session volume of 33,230 shares. The stock had previously closed at $11.01.
Aimei Health Technology Price Performance
The firm's 50-day moving average price is $10.87 and its two-hundred day moving average price is $10.67.
Institutional Trading of Aimei Health Technology
A number of hedge funds have recently bought and sold shares of AFJK. Mizuho Securities USA LLC lifted its stake in shares of Aimei Health Technology by 102.6% during the 4th quarter. Mizuho Securities USA LLC now owns 897,220 shares of the company's stock worth $9,421,000 after purchasing an additional 454,442 shares during the last quarter. Berkley W R Corp bought a new position in Aimei Health Technology in the fourth quarter worth about $4,750,000. Quarry LP purchased a new stake in shares of Aimei Health Technology during the fourth quarter valued at about $1,605,000. Wolverine Asset Management LLC grew its position in shares of Aimei Health Technology by 21.3% in the 4th quarter. Wolverine Asset Management LLC now owns 654,039 shares of the company's stock worth $6,998,000 after buying an additional 115,000 shares during the last quarter. Finally, Harraden Circle Investments LLC bought a new position in shares of Aimei Health Technology during the 4th quarter worth approximately $1,117,000. Hedge funds and other institutional investors own 45.58% of the company's stock.
Aimei Health Technology Company Profile
(
Get Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Read More
Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
